Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • Massachusetts: The State of Possible
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners – SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Termeer Ascend
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
      • Termeer Ascend
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member News

Click to Open Main Menu
News

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

Jun 16, 2022

News

Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis

Jun 15, 2022

Posted by Sumitomo Pharma Oncology, Inc.

News

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

Jun 15, 2022

News

Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology Is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter

Jun 15, 2022

News

Batavia Biosciences increases capacity for viral vectors and vaccine R&D in Netherlands.

Jun 14, 2022

News

Greenberg Traurig’s Melissa Hunter-Ensor Selected as ‘Go To Life Sciences/Healthcare Lawyer’ by Massachusetts Lawyers Weekly

Jun 08, 2022

Posted by Greenberg Traurig, LLP

News

EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences

Jun 07, 2022

News

L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare

Jun 07, 2022

News

L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare

Jun 07, 2022

News

Join CILcare at the Inner Ear Disorders Therapeutics Summit in Boston!

Jun 06, 2022

Posted by Cilcare

News

CILcare will be in San Diego at the BIO International Conference

Jun 06, 2022

Posted by Cilcare

Whitepapers

Five Broad Implications for FDA’s Project Optimus: How to Prepare for the Future of Oncology Trials

Jun 02, 2022

Posted by Halloran Consulting Group, A PLG Company

Page 99 of 207FIRSTPrev...102030...979899100101...110120130...NextLAST
Show Filters

Member Spotlight

Member Spotlight: Symmetric Computing, Inc.

Jun 08, 2026

View All

Featured News

Termeer Ascend's first cohort is already putting leadership into practice

Sep 21, 2026

View All

Sponsor a MassBio Event

Engage with the leading life sciences cluster in the world at a variety of our annual events. Explore our sponsorship opportunities today to position your company for success in 2026 - contact sponsorships@massbio.org.

Learn more

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Join Email List
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2026 All Rights Reserved